TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Swedish Orphan Biovitrum AB (publ)
Closing information (x1000 NOK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
17,773,699
|
15,144,226
|
15,987,446 |
| Financial expenses |
470,119
|
442,751
|
630,656 |
| Earnings before taxes |
3,141,376
|
3,213,357
|
4,417,736 |
| EBITDA |
5,757,770
|
5,590,949
|
7,166,642 |
| Total assets |
49,656,632
|
47,455,288
|
50,581,343 |
| Current assets |
10,604,627
|
8,560,501
|
8,556,809 |
| Current liabilities |
14,053,425
|
8,543,922
|
10,940,102 |
| Equity capital |
25,090,334
|
22,628,081
|
21,167,836 |
| - share capital |
160,805
|
164,813
|
174,949 |
| Employees (average) |
1,556
|
1,559
|
1,509 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
50.5%
|
47.7%
|
41.8% |
| Turnover per employee |
11,423
|
9,714
|
10,595 |
| Profit as a percentage of turnover |
17.7%
|
21.2%
|
27.6% |
| Return on assets (ROA) |
7.3%
|
7.7%
|
10.0% |
| Current ratio |
75.5%
|
100.2%
|
78.2% |
| Return on equity (ROE) |
12.5%
|
14.2%
|
20.9% |
| Change turnover |
3,084,621
|
261,360
|
1,061,220 |
| Change turnover % |
21%
|
2%
|
7% |
| Chg. No. of employees |
-3
|
50
|
174 |
| Chg. No. of employees % |
0%
|
3%
|
13% |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.